SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-19-002247
Filing Date
2019-08-15
Accepted
2019-08-15 13:09:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422gly_08152019.htm SC 13G 207511
2 JOINT FILING AGREEMENT ex991to13g07422gly_08152019.htm EX-99.1 11119
  Complete submission text file 0000921895-19-002247.txt   220179
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87811 | Film No.: 191029512
SIC: 2834 Pharmaceutical Preparations